The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4747-4758

  Xiang, Yufei ^a,b,c   Peng, Jian ^a   Tai, Ningwen ^a   Hu, Changyun ^a   Zhou, Zhiguang ^b,c   Wong, F Susan ^d   Wen, Li ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; IMMUNOGLOBULIN G;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL LOSS; CELL MIGRATION; CELL REGENERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD20; B-LYMPHOCYTE SUBSETS; DIABETES COMPLICATIONS; EPITOPES, T-LYMPHOCYTE; HUMANS; LYMPHOCYTE COUNT; LYMPHOPENIA; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PHENOTYPE; T-LYMPHOCYTE SUBSETS;

EID: 84861133472     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103055     Document Type: Article

References (27)

1. Edwards, J. C., L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D. R. Close, R. M. Stevens, and T. Shaw. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350: 2572-2581. (Pubitemid 38758544)
2. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar- Or, M. Panzara, N. Sarkar, S. Agarwal, et al. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688. (Pubitemid 351240747)
3. Pescovitz, M. D., C. J. Greenbaum, H. Krause-Steinrauf, D. J. Becker, S. E. Gitelman, R. Goland, P. A. Gottlieb, J. B. Marks, P. F. McGee, A. M. Moran, et al. 2009. Rituximab, B-lymphocyte depletion, and preservation of β-cell function. N. Engl. J. Med. 361: 2143-2152.
4. Hu, C. Y., D. Rodriguez-Pinto, W. Du, A. Ahuja, O. Henegariu, F. S. Wong, M. J. Shlomchik, and L. Wen. 2007. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117: 3857-3867. (Pubitemid 350224095)
5. Xiu, Y., C. P. Wong, J. D. Bouaziz, Y. Hamaguchi, Y. Wang, S. M. Pop, R. M. Tisch, and T. F. Tedder. 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcgR effector functions. J. Immunol. 180: 2863-2875.
6. + T-cells control autoimmunity in the absence of B-cells. Diabetes 58: 1568-1577.
7. Fiorina, P., A. Vergani, S. Dada, M. Jurewicz, M. Wong, K. Law, E. Wu, Z. Tian, R. Abdi, I. Guleria, et al. 2008. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes 57: 3013-3024.
8. Herold, K. C., M. D. Pescovitz, P. McGee, H. Krause-Steinrauf, L. M. Spain, K. Bourcier, A. Asare, Z. Liu, J. M. Lachin, H. M. Dosch, et al. 2011. Increased T cell proliferative responses to islet antigens identify clinical responders to anti- CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes. J. Immunol. 187: 1998-2005.
9. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100. (Pubitemid 23289465)
10. Gonzalez, A., J. D. Katz, M. G. Mattei, H. Kikutani, C. Benoist, and D. Mathis. 1997. Genetic control of diabetes progression. Immunity 7: 873-883. (Pubitemid 28064900)
11. Stadinski, B. D., T. Delong, N. Reisdorph, R. Reisdorph, R. L. Powell, M. Armstrong, J. D. Piganelli, G. Barbour, B. Bradley, F. Crawford, et al. 2010. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11: 225-231.
12. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson. 2001. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166: 908-917. (Pubitemid 32060245)
13. Wan, Y. Y., and R. A. Flavell. 2005. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102: 5126-5131.
14. Ahuja, A., J. Shupe, R. Dunn, M. Kashgarian, M. R. Kehry, and M. J. Shlomchik. 2007. Depletion of B cells in murine lupus: efficacy and resistance. J. Immunol. 179: 3351-3361.
15. + regulatory T cells. J. Immunol. 181: 7350-7355.
16. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230. (Pubitemid 34211962)
17. Yang, J. Q., A. K. Singh, M. T. Wilson, M. Satoh, A. K. Stanic, J. J. Park, S. Hong, S. D. Gadola, A. Mizutani, S. R. Kakumanu, et al. 2003. Immuno-regulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis. J. Immunol. 171: 2142-2153. (Pubitemid 36966498)
18. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
19. + phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
20. Pescovitz, M. D. 2010. Treatment of type 1 diabetes with rituximab: 2-year follow-up. In American Diabetes Association 70th Scientific Sessions, June 25-29. Available at: http://professional.diabetes.org/presentations- details.aspx?session=3463. Accessed: March 8, 2011.
21. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278. (Pubitemid 27023727)
22. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710. (Pubitemid 43099663)
23. + T cell immunity. Nat. Rev. Immunol. 10: 236-247.
24. Yang, M., L. Sun, S. Wang, K. H. Ko, H. Xu, B. J. Zheng, X. Cao, and L. Lu. 2010. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J. Immunol. 184: 3321-3325.
25. Hayashi, T., and D. Faustman. 2000. Defective function of the proteasome in autoimmunity: involvement of impaired NF-κB activation. Diabetes Technol. Ther. 2: 415-428.
26. Fan, H., A. Longacre, F. Meng, V. Patel, K. Hsiao, J. S. Koh, and J. S. Levine. 2004. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of macrophages from nonobese diabetic and systemic lupus erythematosusprone mice. J. Immunol. 172: 4834-4843. (Pubitemid 38456406)
27. Anderson, M. S., and J. A. Bluestone. 2005. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485. (Pubitemid 40563177)